← Open Payments lookup

XIAOQING LIU: Open Payments

NPI 1841234002 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,155 in 49 payments from 15 companies in 2025. Trend: 2023 $2,029 · 2024 $2,170 · 2025 $1,155

Food & beverage: $1,136Education: $19
CompanyPaymentsAmount
Axsome Therapeutics, Inc.5$218
ABBVIE INC.13$186
Janssen Pharmaceuticals, Inc6$180
Otsuka America Pharmaceutical, Inc.4$96
E.R. Squibb & Sons, L.L.C.3$78
Lundbeck LLC2$59
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$58
Noven Therapeutics, LLC3$56
Neurocrine BioSciences, Inc.2$55
Bausch Health US, LLC2$44

Products named: Auvelity, VRAYLAR, REXULTI, COBENFY, INVEGA, INVEGA SUSTENNA, CAPLYTA, Xelstrym.

Industry payments across TX — which companies pay providers there.